Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial Active — Not Recruiting NCT03050931

Electrical Impedance Tomography of Epilepsy

Electrical Impedance Tomography of Epilepsy — Active Not Recruiting • Neurology • NCT03050931.

📅 03 Jun 2026 ⏱ 1 min read
Active — Not Recruiting
Check the registry for current status and eligibility criteria.
Status
Active — Not Recruiting
NCT ID
NCT03050931
Start
2017-05-30
Completion
2027-12
ClinicaliQ Trial Snapshot
  • Electrical Impedance Tomography of Epilepsy — Active Not Recruiting • Neurology • NCT03050931.
  • One-sentence summary:.
  • Study testing if EIT brain imaging produces accurate, reproducible results in epilepsy patients compared to MRI, CT, and EEG.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The purpose of this study is to determine if Electrical Impedance Tomography (EIT) can produce reproducible and accurate images in people with epilepsy compared to existing standards such as MRI, CT or EEG. Electrical Impedance Tomography is a relatively new medical imaging method, which has the potential to provide novel images of brain function. It is fast, portable, safe and inexpensive, but currently has a relatively poor spatial resolution. It produces images of the internal electrical impedance of a subject with epilepsy using rings of ECG like electrodes on the…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Motor Neurone Disease: Assessment and Management (NICE NG42)
Neurology · 27 Mar 2026
Refer suspected MND urgently to a specialist neurology centre for diagnosis confirmation by an MND-experienced neurologist using clinical examination, EMG/NCS, imaging, and…
View guideline →
Guideline
Dementia: Assessment, Management and Support (NICE NG97)
Neurology · 25 Mar 2026
Use cognitive testing (MMSE or MoCA) combined with appropriate imaging to confirm dementia diagnosis • Prescribe acetylcholinesterase inhibitors (donepezil, rivastigmine, or galantamine)…
View guideline →
Clinical Brief
AI may speed up search for drugs to treat brain conditions
Neurology · BBC Health · 22 May 2026
AI tools are being developed to accelerate drug discovery for neurological conditions including motor neurone disease, potentially reducing development timelines This approach…
View brief →
Guideline
Headaches in Over 12s: Diagnosis and Management (NICE CG150)
Neurology · 27 Mar 2026
Take a focused history documenting headache onset, frequency, duration, severity, associated symptoms, and functional impact to distinguish primary headaches from secondary causes…
View guideline →
Clinical Brief
Ryan Jones: Unbreakable
Neurology · BBC Health · 02 Sep 2026
Early-onset dementia is occurring in former rugby players, highlighting potential long-term neurological consequences of repeated head trauma sustained during competitive contact sports…
View brief →
Clinical Brief
Student quits university due to epilepsy medicine shortages
Neurology · BBC Health · 03 Aug 2026
Epilepsy medication shortages are affecting patient access – Supply issues are severe enough to impact students' ability to continue their education, highlighting…
View brief →